The Right Way and the Wrong Way to Privatize Science

This isn't America's first time seeing an infusion of personal wealth getting poured into research, but the last time around, it was done more democratically.

http://ift.tt/1vsA2oG

Delving into the pain of osteoarthritis

Her foot pain began 15 years ago, leading to a 2002 diagnosis of osteoarthritis, which left her limping and unable to walk for extended periods of time.

http://ift.tt/1lEQEmj

More Insight Into GDF-11 and Myostatin From Fly Studies

Do you want to live a longer life in good health? Simple practices can make some difference, such as exercise or calorie restriction.

http://ift.tt/1lU9cka

NeoStem Expands Patent Portfolio With Grant of Two European Patents

NeoStem, Inc. , a leader in the emerging cellular therapy industry, today announced the expansion of its intellectual property protection surrounding its CD34 Cell Program in which it is developing therapeutics to address ischemia, the process that occurs when the supply of oxygenated blood in the body is restricted.

http://ift.tt/1mMN5x4

Juventas Therapeutics Data Demonstrates Significant Structural,...

... biologics to the heart," said Warren Sherman, M.D., co-principal investigator for the trial and Director, Stem Cell Research and Regenerative Medicine, Center for Interventional Vascular Therapy, Columbia University Medical Center. "All patients ...

http://ift.tt/1gGvA1q

Ground breaking hip surgery with a 3D printed implant and bone stem cell graft

Doctors and scientists in Southampton have completed their first hip surgery with a 3D printed implant and bone stem cell graft.

http://ift.tt/1oHGPsy

First test of pluripotent stem cell therapy in monkeys is a success

Researchers have shown for the first time in an animal that is more closely related to humans that it is possible to make new bone from stem-cell-like induced pluripotent stem cells made from an individual animal's own skin cells.

http://ift.tt/RODmuq